New insight into combatting drug-resistant prostate cancer

drug-resistant prostate cancer

New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins. Glucocorticoids regulate vital biological processes by affecting gene encoding through […]

Read More… from New insight into combatting drug-resistant prostate cancer

Prostate cancer treatment abiraterone not available

NHS

Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment at the decision by NICE not to recommend abiraterone as a first-line treatment on the NHS for newly diagnosed, advanced prostate cancer. The decision puts the NHS in England and Wales out […]

Read More… from Prostate cancer treatment abiraterone not available